Agilent Technologies, Inc. (A)
NYSE: A · IEX Real-Time Price · USD
131.78
-0.19 (-0.14%)
At close: Jul 19, 2024, 4:00 PM
132.00
+0.22 (0.17%)
Pre-market: Jul 22, 2024, 7:18 AM EDT

Agilent Technologies Revenue

Agilent Technologies had revenue of $6.59B in the twelve months ending April 30, 2024. Revenue in the quarter ending April 30, 2024 was $1.57B. In the fiscal year ending October 31, 2023, Agilent Technologies had annual revenue of $6.83B.

Revenue (ttm)
$6.59B
Revenue Growth
-6.38%
P/S Ratio
5.83
Revenue / Employee
$364,144
Employees
18,100
Market Cap
38.45B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Oct 31, 20236.83B-15.00M-0.22%
Oct 31, 20226.85B529.00M8.37%
Oct 31, 20216.32B980.00M18.36%
Oct 31, 20205.34B176.00M3.41%
Oct 31, 20195.16B249.00M5.07%
Oct 31, 20184.91B442.00M9.88%
Oct 31, 20174.47B270.00M6.43%
Oct 31, 20164.20B164.00M4.06%
Oct 31, 20154.04B-10.00M-0.25%
Oct 31, 20144.05B154.00M3.95%
Oct 31, 20133.89B-2.96B-43.22%
Oct 31, 20126.86B243.00M3.67%
Oct 31, 20116.62B1.17B21.51%
Oct 31, 20105.44B963.00M21.49%
Oct 31, 20094.48B-1.29B-22.39%
Oct 31, 20085.77B354.00M6.53%
Oct 31, 20075.42B447.00M8.99%
Oct 31, 20064.97B288.00M6.15%
Oct 31, 20054.69B129.00M2.83%
Oct 31, 20044.56B88.00M1.97%
Oct 31, 20034.47B-1.54B-25.66%
Oct 31, 20026.01B-2.39B-28.42%
Oct 31, 20018.40B-965.00M-10.31%
Oct 31, 20009.36B2.53B37.06%
Oct 31, 19996.83B-1.12B-14.11%
Oct 31, 19987.95B167.00M2.15%
Oct 31, 19977.79B406.00M5.50%
Oct 31, 19967.38B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Centene 155.52B
Takeda Pharmaceutical 28.16B
GE HealthCare Technologies 19.50B
IQVIA Holdings 15.07B
Haleon 14.31B
Biogen 9.66B
Alcon 9.56B
ResMed 4.58B
Revenue Rankings